A 32-year-old man from rural India presents with a 3-day history of progressive ascending paralysis starting from the legs, followed by facial weakness and diplopia. On examination, he has areflexia and mild respiratory effort increase (RR 24/min). Lumbar puncture shows protein 85 mg/dL with normal cell count. What is the most appropriate immediate next step in management?

Explanation

## Clinical Assessment & Respiratory Monitoring **Key Point:** In Guillain-Barré syndrome (GBS) with progressive weakness and early respiratory involvement signs, the immediate priority is assessment of respiratory reserve and ICU readiness, NOT waiting for confirmatory tests or initiating immunotherapy without baseline respiratory function. **High-Yield:** Respiratory failure is the leading cause of mortality in GBS. Forced vital capacity (FVC) <20 mL/kg or <15 mL/kg predicted, or rapid decline, mandates ICU admission with mechanical ventilation capability on standby. ## Why FVC Assessment Is the Next Step 1. **Timing of intervention:** This patient shows early signs of respiratory compromise (RR 24, facial/bulbar weakness). FVC measurement takes minutes and guides ICU triage immediately. 2. **Prognostic value:** FVC <20 mL/kg is the strongest predictor of need for mechanical ventilation in GBS. 3. **Immunotherapy can proceed in parallel:** Once ICU readiness is confirmed, IVIG or plasmapheresis is initiated without delay. ## Management Sequence in GBS | Step | Timing | Rationale | |------|--------|----------| | **FVC & respiratory assessment** | **Immediate (first 30 min)** | **Determines ICU need; life-saving** | | ICU admission if FVC <20 mL/kg | Concurrent | Airway protection, mechanical ventilation standby | | IVIG or plasmapheresis | Within 24–48 hrs of admission | Immunotherapy; both equally effective if started early | | Nerve conduction studies | Can be done in parallel | Confirms diagnosis but does NOT delay treatment | | Corticosteroids | NOT recommended | No proven benefit in GBS; may worsen outcomes | **Clinical Pearl:** The diagnosis of GBS is clinical + CSF findings (albuminocytologic dissociation). Nerve conduction studies confirm demyelination but should never delay immunotherapy initiation in a patient with classic presentation and respiratory compromise. **Warning:** Corticosteroids alone are ineffective and contraindicated in GBS. Do not delay IVIG/plasmapheresis waiting for NCS confirmation. [cite:Harrison 21e Ch 385]